Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-12-2026-11_15_25-AM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Regulatory
  • Pazdur declines to announce candidacy for vacated FDA commissioner role
  • Regulatory

Pazdur declines to announce candidacy for vacated FDA commissioner role

BioSpace

FDA veteran Richard Pazdur outlined his priorities for the next FDA commissioner but stopped short of putting himself forward as a candidate to lead the agency at an RBC Capital Markets event on Tuesd

Read full story

pharminent May 20, 2026 (Last updated: May 20, 2026)

BioSpace

FDA veteran Richard Pazdur outlined his priorities for the next FDA commissioner but stopped short of putting himself forward as a candidate to lead the agency at an RBC Capital Markets event on Tuesd

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Pepaxti study supports use in wider myeloma population
Next: Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update

Related Stories

  • Regulatory

Novo Nordisk comeback stirs as Wegovy pill wins UK approval

pharminent June 12, 2026
  • Regulatory

Lilly wins new FDA approval for eczema drug Ebglyss

pharminent June 10, 2026
  • Regulatory

Disc’s FDA meeting sets ‘clear path’ for embattled rare blood disease drug

pharminent June 10, 2026

You May Have Missed

  • News

pharminent June 12, 2026
  • Market Access

pharminent June 12, 2026
wp_daily_digest_2026-06-12
  • News

pharminent June 12, 2026
  • Regulatory

Novo Nordisk comeback stirs as Wegovy pill wins UK approval

pharminent June 12, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.